B. Riley Has Bearish Outlook for Hyperfine FY2025 Earnings

Hyperfine, Inc. (NASDAQ:HYPR) – Equities research analysts at B. Riley cut their FY2025 earnings per share (EPS) estimates for Hyperfine in a report released on Monday, November 17th. B. Riley analyst Y. Zhi now forecasts that the company will earn ($0.45) per share for the year, down from their prior forecast of ($0.43). The consensus estimate for Hyperfine’s current full-year earnings is ($0.57) per share. B. Riley also issued estimates for Hyperfine’s Q4 2025 earnings at ($0.08) EPS.

Hyperfine (NASDAQ:HYPR) last posted its quarterly earnings data on Thursday, November 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.01). The firm had revenue of $3.44 million during the quarter, compared to analysts’ expectations of $3.51 million. Hyperfine had a negative return on equity of 97.95% and a negative net margin of 378.17%. Hyperfine has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

HYPR has been the subject of a number of other reports. Lake Street Capital boosted their price objective on shares of Hyperfine from $1.50 to $2.00 and gave the stock a “buy” rating in a report on Thursday, August 14th. Wells Fargo & Company lifted their price objective on Hyperfine from $0.68 to $0.85 and gave the stock an “equal weight” rating in a report on Friday, August 15th. Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperfine in a research note on Wednesday, October 8th. Finally, Wall Street Zen upgraded Hyperfine from a “sell” rating to a “hold” rating in a research report on Saturday, October 25th. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $1.28.

Hyperfine Price Performance

NASDAQ:HYPR opened at $1.07 on Wednesday. The company has a market capitalization of $84.08 million, a price-to-earnings ratio of -2.06 and a beta of 1.08. The business has a 50 day moving average of $1.38 and a 200 day moving average of $1.08. Hyperfine has a 1-year low of $0.53 and a 1-year high of $2.22.

Institutional Trading of Hyperfine

Several large investors have recently modified their holdings of the business. EP Wealth Advisors LLC bought a new position in Hyperfine during the 1st quarter valued at approximately $25,000. Tortoise Investment Management LLC purchased a new position in shares of Hyperfine during the third quarter valued at approximately $65,000. Finally, Vanguard Group Inc. raised its holdings in shares of Hyperfine by 5.7% during the third quarter. Vanguard Group Inc. now owns 3,511,972 shares of the company’s stock valued at $5,092,000 after acquiring an additional 190,136 shares in the last quarter. 15.03% of the stock is owned by institutional investors.

Hyperfine Company Profile

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.